Precision Body Composition Analysis at FIBO 2026: SELVAS Healthcare Inc. Presents ACCUNIQ

Precision Body Analysis at FIBO 2026: SELVAS Healthcare Inc. Presents ACCUNIQ

At this year's FIBO 2026, SELVAS Healthcare Inc. established itself as a significant player in the field of high-precision measurement technology. Focusing on the ACCUNIQ brand, experts from South Korea demonstrated how advanced technology and precision engineering can be utilized to enable exact body composition analysis. The showcased solutions highlight the goal of supporting better diagnosis and targeted treatments in the medical and fitness industries through accurate measurement values.

Technological Precision for Health and Fitness

Central to the presence of SELVAS Healthcare Inc. were specialized body composition analyzers. The exhibition featured models such as the ACCUNIQ BC380 and the ACCUNIQ i35, providing solutions characterized by high quality in body analysis. Such devices are essential for professionals seeking to obtain reliable data regarding physical condition.

The precision of these analytical devices offers significant value to the professional community. Because accurate measurements play a central role in creating individualized treatment or training plans, the presentation of ACCUNIQ technology was a key topic for both trainers and medical professionals alike. By combining technical accuracy with application-oriented development, these devices set high standards in body composition analysis.

A Conclusion to the Fair Presence

With its appearance at FIBO 2026, SELVAS Healthcare Inc. demonstrated the importance of reliable data for success in the health and fitness sectors. The presentation of ACCUNIQ products at stand 6C76 provided a successful contribution to the professional dialogue regarding modern measurement technology.

For more information on these solutions, visit https://www.ACCUNIQ.com/en/.

Further information about the company and its showcased topics is available at https://www.accuniq.com/en/.